Open Access

ASCVD and inflammation: what is the status quo?

logo

Congress Presentation

About the speakers

Doctor Paul M Ridker

Brigham and Women's Hospital, Boston (United States of America)
27 presentations
2 followers

Professor Peter Libby

Brigham and Women's Hospital, Boston (United States of America)
31 presentations
4 followers

Professor Lale Tokgozoglu

Hacettepe University, Ankara (Türkiye)
28 presentations
0 follower

5 more presentations in this session

Welcome video.

Thumbnail

Residual inflammatory risk: concept or clinical practice?

Speaker: Professor P. Libby (Boston, US) Doctor P. Ridker (Boston, US) Professor L. Tokgozoglu (Ankara, TR)

Thumbnail

Anti-inflammatory therapy for ASCVD: what does the future hold?

Speaker: Professor L. Tokgozoglu (Ankara, TR) Professor P. Libby (Boston, US) Doctor P. Ridker (Boston, US)

Thumbnail

Summary and future directions.

Speaker: Professor P. Libby (Boston, US)

Thumbnail

Access the full session

Inflammation in atherosclerotic cardiovascular disease (ASCVD): the spark before the fire?

Speakers: Doctor P. Ridker, Professor P. Libby, Professor L. Tokgozoglu, Professor P. Libby, Doctor P. Ridker...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk